In addition, we investigated the DDX27 genetic alterations among a GC cohort (OncoSG, 2018) with whole-genome sequencing and found that DDX27 amplification account for about 21%, indicating a high frequency of amplification of DDX27 among the clinical GC patients. The gene discussed is DDX27; the disease is gastric cancer.